Credit Suisse Upgrades St. Jude Medical (STJ) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
St. Jude Medical (STJ) PT Lifted to $82 at Wedbush Following Strong Q1
April 23, 2015 7:55 AM EDTWedbush analyst Tao Levy reiterated an Outperform rating and raised his price target on St. Jude Medical (NYSE: STJ) to $82.00 (from $77.00) following "impressive" Q1 results.
Levy commented, "Impressive 1Q results for St. Jude Medical, driven by CardioMEMS, Atrial Fibrillation, and Neuromodulation; bodes well... More
St. Jude Medical (STJ) Price Target Lifted to $86 at Needham & Company
April 22, 2015 11:28 AM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy rating and raised his price target on St. Jude Medical (NYSE: STJ) to $86.00 (from $83.00)
Matson commented, "STJ's 1Q15 revenue and EPS beat consensus. Management raised its 2015 constant currency revenue guidance given better than expected 1Q15 growth and... More
St. Jude Medical (STJ) Tops Q1 EPS by 2c; Guides Q1 EPS to Strong-Side of Views
April 22, 2015 7:16 AM EDTSt. Jude Medical (NYSE: STJ) reported Q1 EPS of $0.93, $0.02 better than the analyst estimate of $0.91. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.32 billion.
Outlook:
St. Jude Medical sees Q2 2015 EPS of $0.99 - $1.01, versus... More
